Focusing on a product spread

THE INVESTMENT COLUMN

The last year or so has been a period of consolidation for SmithKline Beecham, after a period of giddy expansion for the drugs giant in 1994. In May that year it paid $2.3bn (pounds 1.6bn) for Diversified Pharmaceutical Services, went on to pick up the consumer health-care operations of Sterling Winthrop for $2.9bn and two weeks later off-loaded part of that deal in a $1bn disposal to Bayer. Along the way, the group dumped its animal healthcare operation on Pfizer.

The resulting spread of health-related products at the reshaped SmithKline Beecham was evident in yesterday's announcement that it had received US regulatory approval both for a new dosage for its Augmentin antibiotic and an over-the-counter version of the Nicorette anti-smoking treatment. Unlike others in the sector, the group has taken a deliberate view that there is money to be made both in so-called ethical patented pharmaceuticals like Augmentin and in self-medication, ranging from Panadol analgesics to Nicorette.

It is a strategy that has raised some eyebrows amongst pharmaceutical analysts, given the prevailing fashion for focus.

In drugs groups, current received wisdom has it that the big ones should focus on a few "blockbuster" treatments. Instead, the Sterling buy took SmithKline further into the consumer area.

But the surprises have been good so far, with an encouraging recent report on its drugs pipeline, in contrast to more lacklustre showings from rivals Zeneca and Glaxo Wellcome.

The shares' 23 per cent outperformance against the rest of the market over the past 12 months says as much about the ferment affecting the rest of the market as SmithKline Beecham's performance, however. Glaxo's pounds 9bn purchase of Wellcome and the mega deals in the US set shares in the sector alight in 1995 and there has been strong US buying of SmithKline units, the more actively traded of the group's two classes of shares in New York.

But as results out next Tuesday should show, the group has been doing an effective job of managing the decline of its one-time best-seller, the anti-ulcer drug Tagamet.

That is expected to have seen its sales slump from pounds 480m in 1994, when it went off patent, to just pounds 280m last year. Seroxat, the anti-depressant competitor to Eli Lilley's Prozac, could have seen sales rise from pounds 333m to pounds 474m, while the Engerix-B hepatitis vaccine could be near to the pounds 400m mark with Augmentin showing continued growth. Consumer health is expected to have done well and chief executive Jan Leschly has promised double digit earnings growth going forward.

The problem is that all the good news is in the share price, which stands on close to 22 times last year's estimated earnings and 19 times the current year's forecast. Any slippage will take its toll on the shares which are high enough.

Start your day with The Independent, sign up for daily news emails
ebooks
ebooksA special investigation by Andy McSmith
  • Get to the point
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Ashdown Group: Treasury Assistant - Accounts Assistant - London, Old Street

£24000 - £26000 per annum + benefits : Ashdown Group: A highly successful, glo...

Ashdown Group: Business Analyst - Financial Services - City, London

£50000 - £55000 per annum: Ashdown Group: Business Analyst - Financial Service...

SThree: Trainee Recruitment Consultant

£18000 - £23000 per annum + OTE £45K: SThree: At SThree, we like to be differe...

SThree: Trainee Recruitment Consultant

£20000 - £25000 per annum + competitive: SThree: Did you know? SThree is the o...

Day In a Page

General Election 2015: Chuka Umunna on the benefits of immigration, humility – and his leader Ed Miliband

Chuka Umunna: A virus of racism runs through Ukip

The shadow business secretary on the benefits of immigration, humility – and his leader Ed Miliband
Yemen crisis: This exotic war will soon become Europe's problem

Yemen's exotic war will soon affect Europe

Terrorism and boatloads of desperate migrants will be the outcome of the Saudi air campaign, says Patrick Cockburn
Marginal Streets project aims to document voters in the run-up to the General Election

Marginal Streets project documents voters

Independent photographers Joseph Fox and Orlando Gili are uploading two portraits of constituents to their website for each day of the campaign
Game of Thrones: Visit the real-life kingdom of Westeros to see where violent history ends and telly tourism begins

The real-life kingdom of Westeros

Is there something a little uncomfortable about Game of Thrones shooting in Northern Ireland?
How to survive a social-media mauling, by the tough women of Twitter

How to survive a Twitter mauling

Mary Beard, Caroline Criado-Perez, Louise Mensch, Bunny La Roche and Courtney Barrasford reveal how to trounce the trolls
Gallipoli centenary: At dawn, the young remember the young who perished in one of the First World War's bloodiest battles

At dawn, the young remember the young

A century ago, soldiers of the Empire – many no more than boys – spilt on to Gallipoli’s beaches. On this 100th Anzac Day, there are personal, poetic tributes to their sacrifice
Dissent is slowly building against the billions spent on presidential campaigns – even among politicians themselves

Follow the money as never before

Dissent is slowly building against the billions spent on presidential campaigns – even among politicians themselves, reports Rupert Cornwell
Samuel West interview: The actor and director on austerity, unionisation, and not mentioning his famous parents

Samuel West interview

The actor and director on austerity, unionisation, and not mentioning his famous parents
General Election 2015: Imagine if the leading political parties were fashion labels

Imagine if the leading political parties were fashion labels

Fashion editor, Alexander Fury, on what the leaders' appearances tell us about them
Phumzile Mlambo-Ngcuka: Home can be the unsafest place for women

Phumzile Mlambo-Ngcuka: Home can be the unsafest place for women

The architect of the HeForShe movement and head of UN Women on the world's failure to combat domestic violence
Public relations as 'art'? Surely not

Confessions of a former PR man

The 'art' of public relations is being celebrated by the V&A museum, triggering some happy memories for DJ Taylor
Bill Granger recipes: Our chef succumbs to his sugar cravings with super-luxurious sweet treats

Bill Granger's luxurious sweet treats

Our chef loves to stop for 30 minutes to catch up on the day's gossip, while nibbling on something sweet
London Marathon 2015: Paula Radcliffe and the mother of all goodbyes

The mother of all goodbyes

Paula Radcliffe's farewell to the London Marathon will be a family affair
Everton vs Manchester United: Steven Naismith demands 'better' if Toffees are to upset the odds against United

Steven Naismith: 'We know we must do better'

The Everton forward explains the reasons behind club's decline this season
Arsenal vs Chelsea: Praise to Arsene Wenger for having the courage of his convictions

Michael Calvin's Last Word

Praise to Wenger for having the courage of his convictions